Loss of A1 adenosine receptors in human temporal lobe epilepsy

Brain Research

Volumn 710, Issue 1-2, 1996, Pages 56-68

  Glass, M ^a   Faull, R L M ^a   Bullock, J Y ^a   Jansen, K ^a   Mee, E W ^b   Walker, E B ^b   Synek, B J L ^a   Dragunow, M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Glutamate; Purine; Seizure

Indexed keywords

ADENOSINE A1 RECEPTOR; BENZODIAZEPINE RECEPTOR; CARBAMAZEPINE; CLOBAZAM; GLUTAMATE RECEPTOR; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; BRAIN HOMOGENATE; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; TEMPORAL LOBE;

EID: 0029882167     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01313-X     Document Type: Article

References (58)

1. Albertson, T.E., Joy, R.M. and Stark, L.G., Modification of amygdaloid seizures by caffeine, Soc. Neurosci. Abstr., 8 (1982) 457.
2. Albertson, T.E., Stark, L.G., Joy, R.M. and Bowyer, J.F., Aminophylline and kindled seizures, Exp. Neurol., 81 (1983) 703-713.
3. Angelatou, F., Pagonopoulou, O. and Kostopoulos, G., Alterations of the A1 receptors in different mouse brain areas after pentylentetrazol induced seizures, but not in the epileptic mutant mouse 'tottering', Brain Res., 534 (1990) 251-256.
4. Angelatou, F., Pagonopoulou, O., Maraziotis, T., Olivier, A., Villemeure, J.G., Avoli, M. and Kostopoulos, G., Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study, Neurosci. Lett., 163 (1993) 11-14.
5. Barraco, R.E., Swanson, T.H., Phillis, J.W. and Berman, R.F., Anticonvulsant effects of adenosine analogs on amygdaloid-kindled seizures in rats, Neurosci. Lett., 46 (1984) 317-322.
6. Chu, N.S., Caffeine and aminophylline-induced seizures, Epilepsia, 22 (1981) 85-94.
7. Daval, J.L., Deckert, J., Weiss, S.R., Post, R.M. and Marangos, P.J., Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitative autoradiographic study, Epilepsia, 30 (1989) 26-33.
8. Daval, J.L. and Sarfati, A., Effects of bicuculline-induced seizures on benzodiazepine and adenosine receptors in the developing rat brain, Life Sci., 41 (1987) 1685-1693.
9. Daval, J.L. and Werck, M.C., Autoradiographic changes in brain adenosine A1 receptors and their coupling to G-proteins following seizures in the developing rat, Dev. Brain Res., 59 (1993) 1237-1247.
10. Daval, J.L., Werck, M.C., Neblig, A. and Pereira de Vasconcelos, A., Quantitative autoradiographic study of post-natal development of adenosine A1 receptors and their coupling to G-proteins in rat brain, Neuroscience, 40 (1991) 841-851.
11. Dragunow, M., Adenosine: the brain's natural anticonvulsant?, Trends Pharmacol. Sci., 18 (1986) 128-130.
12. Dragunow, M., Purinergic mechanisms in epilepsy, Prog. Neurobiol., 31 (1988) 85-108.
13. Dragunow, M., Adenosine receptor antagonism accounts for the seizure prolonging effects of aminophylline, Pharmacol. Biochem. Behav., 36 (1990) 751-755.
14. Dragunow, M., Goddard, G.V. and Laverty, R., Is adenosine an endogenous anti-convulsant, Epilepsia, 26 (1985) 480-487.
15. Dragunow, M. and Robertson, H.A., 8-Cyclopentyl-1-3-dimethyl-xanthine prolongs epileptic seizures in rats, Neurosci. Lett., 74 (1987) 320-324.
16. Dragunow, M. and Goddard, G.V., Adenosine modulation of amygdala kindling, Exp. Neurol., 84 (1984) 654-665.
17. Dunwiddie, T.V., Endogenously released adenosine regulates excitability in the in vitro hippocampus, Epilepsia, 21 (1980) 541-548.
18. Dunwiddie, T.V. and Worth, T., Sedative and anti-convulsant effects of adenosine analogs in mouse and rat, J. Pharmacol. Exp. Ther., 220 (1982) 70-76.
19. During, M.J. and Spencer, D.D., Neurotransmitter release in the human hippocampus in vivo: physiological and pharmacological studies of complex partial epilepsy, Epilepsia, 31 (1990) 623-624.
20. During, M.J. and Spencer, D.D., Adenosine: a mediator of seizure arrest and postictal refractoriness, Ann. Neurol., 32 (1992) 618-624.
21. During, M.J. and Spencer, D.D., Extracellular hippocampal glutamate and spontaneous seizures in the conscious human brain, Lancet, 341 (1993) 1607-1610.
22. Eldridge, F.L., Paydarfar, D., Scott, S.C. and Dowell, R.T., Role of endogenous adenosine in recurrent generalised seizures, Exp. Neurol., 103 (1989) 179-185.
23. Fastbom, J., Pazos, A., Probst, A. and Palacios, J.M., Adenosine A1 receptors in the human brain: characterisation and autoradiographic visualisation, Neurosci. Lett., 65 (1986) 127-132.
24. Fastbom, J., Pazos, A., Probst, A. and Palacios, J.M., Adenosine A1 receptors in the human brain a quantitative autoradiographic study, Neuroscience, 22 (1987) 827-839.
25. García-Ladona, F.J., Palacios, J.M., Probst, A., Wieser, H.G. and Mengod, G., Excitatory amino acid AMPA receptor mRNA localization in several regions of normal and neurological disease affected human brain - an in situ hybridization histochemistry study, Mol. Brain Res., 21 (1994) 75-84.
26. Geddes, J.W., Cahan, L.D., Cooper, S.M., Kim, R.C., Choi, B.H. and Cotman, C.W., Altered distribution of excitatory amino acid receptors in temporal lobe epilepsy, Exp. Neurol., 108 (1990) 214-220.
27. Gleiter, C.H., Deckert, J., Nuit, D.J. and Marangos, P.J., Electroconvulsive shock (ECS) and the adenosine neuromodulatory system: effect of single and repeated ECS on the adenosine A1 and A2 receptors, adenylate cyclase and the adenosine uptake site, J. Neurochem., 52 (1989) 641-646.
28. Goodman, R.R. and Snyder, S.H., Autoradiographic localisation of adenosine receptors in the rat brain using [3H]CHA, J. Neurosci., 2 (1982) 1230-1241.
29. Haas, H.L. and Jefferies, J.G.R., Low calcium field burst discharges of CA1 pyramidal neurons in rat hippocampal slices, J. Physiol., 354 (1984) 185-201.
30. Henry, T.R., Frey, K.A., Sackellares, J.C., Gilman, S., Koeppe, R.A., Brunberg, J.A., Ross, D.A., Berent, S., Young, A.B. and Kuhl, D.E., In vivo cerebral metabolism and central benzodiazepine receptor binding in temporal lobe epilepsy, Neurology, 43 (1993) 1998-2006.
31. Hosford, D.A., Crain, B.J., Bonhaus, D.W., Friedman, A.H., Nadler, J.V. and McNamara, J.O., Radiohistochemical demonstration of altered quisqualate and NMDA receptor channel binding in epileptic patients, Epilepsia, 30 (1989) 719.
32. Hosford, D.A., Crain, B.J., Cao, Z., Bonhaus, D.W., Friedman, A.H., Okazaki, M.M., Nadler, J.V. and McNamara, J.O., Increased AMPA-sensitive quisqualate receptor binding and reduced NMDA receptor binding in epileptic human hippocampus, J. Neurosci., 11 (1991) 428-434.
33. Jansen, K.L.R., Faull, R.L.M. and Dragunow, M., Excitatory amino acid receptors in the human cerebral cortex: a quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]Glycine, L-[3H]Glutamate, [3H]AMPA and [3H]Kainic acid binding sites, Neuroscience, 32 (1989) 587-607.
34. Jansen, K.L.R., Faull, R.L.M., Dragunow, M. and Synek, B.L., Alzheimers disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors - an autoradiographic study, Neuroscience, 39 (1990) 613-627.
35. Jarvis, M.F., Jackson, R.H. and Williams, M., Autoradiographic characterisation of high affinity adenosine A2 receptors in the rat brain, Brain Res., 484 (1989) 111-118.
36. Johnson, E.W., de Lanerolle, N.C., Kim, J.H., Sundaresan, S., Spencer, D.D., Mattson, R.H., Zoghbi, S.S., Baldwin, R.M., Hoffer, P.B., Seibyl, J.P. and Innis, R.B., 'Central' and 'peripheral' benzodiazepine receptors: opposite changes in human epileptogenic tissue, Neurology, 42 (1992) 811-815.
37. Kostopoulos, G., Drapeau, C., Avoli, M., Olivier, A. and Villemeure, J.G., Endogenous adenosine can reduce epileptiform activity in human epileptic cortex maintained in vitro, Neurosci. Lett., 106 (1989) 119-124.
38. Lee, K.S., Reddington, M., Schubert, P. and Kreutzberg, G., Regulation of the strength of adenosine modulation in the hippocampus by a differential distribution of the density of A1 receptors, Brain Res., 260 (1983) 156-159.
39. Linden, J., Adenosine deaminase for removing adenosine: how much is enough?, Trends Pharmacol. Sci., 10 (1989) 260-262.
40. Marangos, P.J., Montgomery, P., Weiss, S.R.B., Patel, J. and Post, R.M., Persistant up-regulation of brain receptors in response to chronic carbamazepine treatment, Clin. Neuropharmacol., 16 (1987) 443-448.
41. Marangos, P.J., Weiss, S.R., Montgomery, P., Patel, J., Narang, P.K., Cappabianca, A.M. and Post, R.M., Chronic carbamazepine treatment increases brain adenosine receptors, Epilepsia, 26 (1985) 493-498.
42. Margerison, J.H. and Corsellis, J.A.N., Epilepsy and the temporal lobes: a clinical encepthalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes, Brain, 89 (1966) 499-530.
43. McDonald, J.W., Garofalo, E.A., Hood, T., Sckellares, J.C., Gilman, S., McKeever, P.E., Troncoso, J.C. and Johnston, M.V., Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy, Ann. Neurol., 29 (1991) 529-541.
44. Pagonopoulou, O. and Angelatou, F., Reduction of A1 adenosine receptors in cortex, hippocampus and cerebellum in aging mouse brain, NeuroReport, 3 (1992) 735-737.
45. Savic, F., Persson, A., Roland, P., Pauli, S., Sepiall, G. and Widen, L., In vivo demonstraiton of reduced BZ receptor binding in human epileptic foci, Lancet, 2 (1988) 863-866.
46. Savic, F., Widen, L., Thorell, J.O., Blomquist, G., Ericson, K. and Roland, P., Cortical Benzodiazepine receptor binding in patients with generalized and partial epilepsy, Epilepsia, 31 (1990) 724-730.
47. Savic, I., Ingvar, M. and Stone-Elander, S., Comparison of [11C]-flumazenil and [18F]FDG as PET markers of epileptic foci, J. Neurol. Neurosurg. Psychiatry, 56 (1993) 615-621.
48. Sherwin, A., Matthew, E., Blain, M. and Guevrement, D., Benzodiazepine receptor binidng is not altered in human epileptogenic cortical foci, Neurology, 36 (1986) 1380-1382.
49. Sherwin, A., Olivier, A., Quesney, F., Robitaille, Y., Andermann, E., Andermann, F., Feindel, W. and Kish, S., Glutamate and aspartate but not GABA or taurine concentrations are elevated in actively spiking versus non-spiking human epileptic cortex, Neurology, 37 (1987) 247.
50. Sherwin, A., Robitaille, Y. and Quesney, F., Excitatory amino acids are elevated in human epileptic cerebral cortex, Neurology, 38 (1988) 920-923.
51. Sironi, V.A., Cabrini, G., Porro, M.G., Ravagnati, L. and Marossero, F., Anti-epileptic drug distribution in the cerebral cortex, ammons horn and amygdala in man, J. Neurosurg., 52 (1980) 686-692.
52. Stratton, K.R., Cole, A.J., Pritchett, J., Ecceles, C.U., Worley, P.F. and Baraban, J.M., Intrahippocampal injeciton of pertussis toxin blocks adenosine supression of synaptic responses, Brain Res., 494 (1989) 359-364.
53. Van Calker, D., Steber, R., Klotz, K.M. and Greil, W., Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses, Eur. J. Pharmacol. -Mol. Pharmacol., 206 (1991) 285-290.
54. Walker, J.E., Aminophylline seizures in the rat, J. Pharm. Pharmacol., 33 (1981) 479-480.
55. Winn, H.R., Rubio, R. and Berne, R.M., Brain adenosine concentrations during hypoxia in rats, Am. J. Physiol., 241 (1981) h235-h242.
56. Wyler, A.L., Nadi, N.S. and Porter, P.J., Acetylcholine, GABA, benzodiazepine and glutamate receptors in the temporal lobe of epileptic patients, Neurology, 37 (1987) 103.
57. Young, D. and Dragunow, M., Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms, Neuroscience, 58 (1994) 245-261.
58. Zwillich, C.W., Sutton, F.D., Neff, T.A., Cohn, W.M., Maitay, R.A. and Weinberger, M.M., Theophylline induced seizures in adults, Ann. Intern. Med., 82 (1975) 784-787.